Suvretta Capital Management’s Zura Bio ZURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$39.3M Hold
9,443,001
– – 0.91% 31
2026
Q2
$55.7M Buy
9,443,001
+376,000
+4% +$1.79M 1.02% 28
2026
Q1
$53.9M Buy
9,067,001
+3,500,000
+63% +$21.1M 1.38% 28
2025
Q4
$29.2M Buy
5,567,001
+94,110
+2% +$372K 0.6% 47
2025
Q3
$23.7M Buy
5,472,891
+611,952
+13% +$1.1M 0.61% 50
2025
Q2
$5.1M Hold
4,860,939
– – 0.15% 62
2025
Q1
$6.27M Hold
4,860,939
– – 0.23% 61
2024
Q4
$12.2M Hold
4,860,939
– – 0.41% 53
2024
Q3
$19.7M Hold
4,860,939
– – 0.63% 48
2024
Q2
$17M Buy
4,860,939
+2,010,939
+71% +$8.2M 0.63% 42
2024
Q1
$7.32M Hold
2,850,000
– – 0.27% 57
2023
Q4
$13.3M Hold
2,850,000
– – 0.6% 43
2023
Q3
$18.8M Hold
2,850,000
– – 1.02% 31
2023
Q2
$23.4M Buy
+2,850,000
New +$22.9M 1.25% 29

Other funds holding ZURA

Suvretta Capital Management's ZURA Position: Q3 2026 in Review

Suvretta Capital Management held its Zura Bio (ZURA) position steady in Q3 2026 at 9,443,001 shares worth $39.3M. The position accounts for 0.91% of the portfolio, ranked #31.

Suvretta Capital Management first reported a position in ZURA in Q2 2023 and has held it in 14 quarters since. The position peaked at $55.7M in Q2 2026. 122 funds tracked by Wall St. Rank hold ZURA as of Q3 2026.

  • Suvretta Capital Management held 9,443,001 shares of Zura Bio worth $39.3M as of Q3 2026.
  • Suvretta Capital Management left its Zura Bio share count unchanged in Q3 2026.
  • Zura Bio made up 0.91% of Suvretta Capital Management's portfolio in Q3 2026, its #31 holding.
  • Suvretta Capital Management first reported a position in Zura Bio in Q2 2023 and has held it in 14 quarters since.
  • Suvretta Capital Management's Zura Bio position peaked at $55.7M in Q2 2026.
  • 122 funds tracked by Wall St. Rank held Zura Bio as of Q3 2026.

Based on Suvretta Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.